JMP Securities Sticks to Their Buy Rating for Cytokinetics (CYTK)
JMP Securities analyst Jason Butler maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $78.00.
JMP Securities Sticks to Its Hold Rating for The RMR Group (RMR)
JMP Securities analyst Mitchell Germain maintained a Hold rating on The RMR Group (RMR – Research Report) today. The company’s shares closed ...
Roku, Inc. (ROKU): Among Cathie Wood’s Top Stock Picks for 2025
Roku Inc. (NASDAQ:ROKU) posted excellent fiscal third-quarter 2024 results, exceeding $1 billion in total net sales for the ...
JMP Securities Raises Axon Enterprise, Inc. (AXON) Price Target to $725 on AI & Defense Demand
We recently compiled a list of the 8 AI Stocks on Investors’ Radar. In this article, we are going to take a look at where ...
Horace Mann targets $3.60-$3.90 EPS in 2025 with profitability improvements
Full-year 2024 core EPS reached $3.18, more than double the 2023 results, with a core return on equity of 8.8%. She highlighted that the company has fully restored Property & Casualty profitability, ...
Dohj LLC Increases Position in Meta Platforms, Inc. (NASDAQ:META)
Dohj LLC boosted its position in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 5.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC.